CPT1C overexpression is associated with higher in vitro cell survival and in vivo tumour growth, especially in conditions of metabolic stress (hypoxia or glucose deprivation) [10,12,13,22,23,24,25] and also with poorer overall survival [24,26]. Here, CPT1C is linked to neoplasm.